Regular infusions of a peptide that can selectively seek out and destroy broken-down cells that hamper proper tissue renewal, called senescent cells, showed evidence of improving healthspan in naturally-aged mice and mice genetically engineered to rapidly age.
The proof-of-concept study, published March 23 in Cell, found that an anti-senescent cell therapy could reverse age-related loss of fur, poor kidney function, and frailty. It is currently being tested whether the approach also extends lifespan, and human safety studies are being planned.
The peptide took over four years of trial and error to develop and builds on nearly a decade of research investigating vulnerabilities in senescent cells as a therapeutic option to combat some aspects of aging (Trends in Molecular Medicine, 10.1016/j.molmed.2016.11.006). It works by blocking the ability of a protein implicated in senescence, FOXO4, to tell another protein, p53, not to cause the cell to self-destruct. By interfering with the FOXO4-p53 crosstalk, the peptide causes senescent cells to go through apoptosis, or cell suicide.
“Only in senescent cells does this peptide cause cell death,” says senior author Peter de Keizer, a researcher of aging at Erasmus University Medical Center in the Netherlands. “We treated mice for over 10 months, giving them infusions of the peptide three times a week, and we didn’t see any obvious side effects. FOXO4 is barely expressed in non-senescent cells, so that makes the peptide interesting as the FOXO4-p53 interaction is especially relevant to senescent cells, but not normal cells.”
Results appeared at different times over the course of treatment. Fast-aging mice with patches of missing fur began to recover their coats after 10 days. After about three weeks, fitness benefits began to show, with older mice running double the distance of their counterparts who did not receive the peptide. A month after treatment, aged mice showed an increase in markers indicating healthy kidney function.
Senescent cell therapy is one of several strategies being tested in mice aimed at reversing aging or lengthening healthspan. In 2015, the Valter Longo laboratory at the University of Southern California reported that mice on a calorie-restricted diet that mimics fasting benefited from a longer life, a reduction in inflammatory disease, and improved memory (Cell Metabolism, 10.1016/j.cmet.2015.05.012). And last December, Juan Carlos Izpisua Belmonte at the Salk Institute of Biological Science and colleagues made headlines with their discovery that cellular reprogramming of epigenetic marks could extend lifespan and improve health in fast-aging mice (Cell, 10.1016/j.cell.2016.11.052).
“This wave of research on how we can fight aging is complementary, and not in competition,” says de Keizer. “The common thread I see for the future of anti-aging research is that there are three fronts in which we can improve: The prevention of cellular damage and senescence, safe therapeutic removal of senescent cells, to stimulate stem cells–no matter the strategy–to improve tissue regeneration once senescence is removed.”
de Keizer aims to start a company based on these findings, but in the short term, he and his group want to show that their peptide is non-toxic in humans with no unforeseen side effects. They plan to offer a safety clinical trial in people with Glioblastoma multiforme, an aggressive brain tumor, which also shows high levels of the biomarkers needed for this FOXO4 peptide to be effective.
Learn more:Â Peptide targeting senescent cells restores stamina, fur, and kidney function in old mice
[osd_subscribe categories=’anti-senescent-cell-therapy’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “ANTI-SENESCENT CELL THERAPY”‘]
The Latest on: Anti-senescent cell therapy
[google_news title=”” keyword=”anti-senescent cell therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Anti-senescent cell therapy
- Strengthening CAR-T therapy to work against solid tumorson May 8, 2024 at 11:00 am
Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to ...
- Hacking the immune system could slow ageing — here’s howon May 6, 2024 at 4:59 pm
Yet all she had done was to briefly treat them — many weeks earlier — with a drug that corrected the organization of proteins inside a type of stem cell. When technicians who were replicating her ...
- New Technique to Identify Anti-Aging Moleculeson April 30, 2024 at 1:11 pm
As the human body ages, cellular changes can drive a host of age-related diseases and conditions. The appearance of aging cells, also called senescent cells, in age-related diseases has spurred the ...
- Research reports on senescent characteristics of human corneal endothelial cells upon UV-A exposureon April 30, 2024 at 12:25 pm
A new research paper titled "Senescent characteristics of human corneal endothelial cells upon ultraviolet-A exposure" has been published on the cover of Aging.
- Cover paper: Senescent characteristics of human corneal endothelial cells upon UV-A exposureon April 30, 2024 at 12:04 pm
these findings may help to advance our understanding of the pathogenesis of corneal endothelial disease and may lead to the discovery of new therapies targeting senescent cells.” “We assessed ...
- Celebrities Quietly Paying Huge Amounts for Anti-Aging Stem Cell Therapy That May Cause Gruesome Side Effectson April 27, 2024 at 6:31 am
Experts caution that there's limited evidence backing the benefits of these stem cell treatments, while pointing to plenty of risks.
- The murky, unregulated world of anti-ageing stem cell therapyon April 24, 2024 at 11:52 am
In an interview with Saga magazine, Cleese described receiving a treatment which he appeared to describe as a form of ongoing anti-ageing maintenance. “These cells travel around the body and ...
- The murky, unregulated world of anti-ageing stem cell therapyon April 24, 2024 at 10:50 am
Stem cells are the new focal point of the rich and famous with Hollywood A-listers reportedly spending tens of thousands of pounds each year on expensive therapies offered by private longevity clinics ...
- Alzheimer’s Disease Neurons Reenter Cell Cycle, Become Senescenton April 23, 2024 at 3:56 pm
Senescent cells displayed more proinflammatory, metabolically deregulated, and pathology-associated signatures ...
via Bing News